Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-17-000010

Options or other derivatives

  • CEO / President acquired 14,293 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K. · CEO / President

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-15 Grant or award : show line 1 in the form Options to buy Common Stock +14,293 $0.44 $6,289 14,293 D
Loading xslF345X03/primary_doc.xml…